CY1118117T1 - Νεα αμινο-πυρρολινικα παραγωγα και η χρηση τους στην προληψη ή και τη θεραπεια του μεταβολικου συνδρομου - Google Patents

Νεα αμινο-πυρρολινικα παραγωγα και η χρηση τους στην προληψη ή και τη θεραπεια του μεταβολικου συνδρομου

Info

Publication number
CY1118117T1
CY1118117T1 CY20161100829T CY161100829T CY1118117T1 CY 1118117 T1 CY1118117 T1 CY 1118117T1 CY 20161100829 T CY20161100829 T CY 20161100829T CY 161100829 T CY161100829 T CY 161100829T CY 1118117 T1 CY1118117 T1 CY 1118117T1
Authority
CY
Cyprus
Prior art keywords
prevention
treatment
metabolic syndrome
pyrroline
products
Prior art date
Application number
CY20161100829T
Other languages
English (en)
Inventor
Pascal Bousquet
Jean-Daniel Ehrhardt
Lyne Fellmann
Vincent Gasparik
Hugues Greney
Mohamed Hadjeri
André Mann
Nathalie Niederhoffer
Stephan Schann
Original Assignee
Université De Strasbourg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR1153375A external-priority patent/FR2974364B1/fr
Application filed by Université De Strasbourg filed Critical Université De Strasbourg
Publication of CY1118117T1 publication Critical patent/CY1118117T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Νέα αμινο-πυρρολινικά παράγωγα, τα φαρμακολογικά αποδεκτά άλατα τους και η χρήση τους στην πρόληψη ή και τη θεραπεία του μεταβολικού συνδρόμου.
CY20161100829T 2011-04-19 2016-08-22 Νεα αμινο-πυρρολινικα παραγωγα και η χρηση τους στην προληψη ή και τη θεραπεια του μεταβολικου συνδρομου CY1118117T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1153375A FR2974364B1 (fr) 2011-04-19 2011-04-19 Nouveaux derives amino-pyrroliniques, leur utilisation dans la prevention et/ou le traitement du syndrome metabolique
FR1251302 2012-02-13
PCT/FR2012/050835 WO2012143660A1 (fr) 2011-04-19 2012-04-17 Nouveaux derives amino-pyrroliniques, leur utilisation dans la prevention et/ou le traitement du syndrome metabolique

Publications (1)

Publication Number Publication Date
CY1118117T1 true CY1118117T1 (el) 2017-06-28

Family

ID=46146922

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100829T CY1118117T1 (el) 2011-04-19 2016-08-22 Νεα αμινο-πυρρολινικα παραγωγα και η χρηση τους στην προληψη ή και τη θεραπεια του μεταβολικου συνδρομου

Country Status (17)

Country Link
US (1) US9303019B2 (el)
EP (1) EP2699545B1 (el)
JP (1) JP5986625B2 (el)
CN (1) CN103619814B (el)
CA (1) CA2833339C (el)
CY (1) CY1118117T1 (el)
DK (1) DK2699545T3 (el)
ES (1) ES2588059T3 (el)
HR (1) HRP20161024T1 (el)
HU (1) HUE030432T2 (el)
LT (1) LT2699545T (el)
PL (1) PL2699545T3 (el)
PT (1) PT2699545T (el)
RS (1) RS55061B1 (el)
SI (1) SI2699545T1 (el)
SM (1) SMT201600284B (el)
WO (1) WO2012143660A1 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015014191B1 (pt) * 2012-12-19 2019-08-27 Bayer Cropscience Ag indanil carboxamidas difluorometilnicotínicas
WO2023084054A1 (en) 2021-11-12 2023-05-19 3Z Ehf Treatment of adhd using selective binders of the 11-imidazoline receptor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670859A1 (de) * 1967-04-24 1971-03-11 Bayer Ag Verfahren zur Herstellung von 2-Phenyl-imino-1-azacycloalkanen
US3679692A (en) * 1969-10-01 1972-07-25 Mead Johnson & Co Iminomethylindolines
US4533739A (en) * 1982-10-12 1985-08-06 G. D. Searle & Co. 2-[(Aminophenyl and amidophenyl)amino]-1-azacycloalkanes having antidiarrheal activity
US4579951A (en) * 1984-03-19 1986-04-01 G. D. Searle & Co. Substituted (azacycloalk-2-yl)iminophenols and esters thereof
EP2486009B1 (en) * 2009-10-06 2019-08-21 Allergan, Inc. 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators
EP2491017B1 (en) * 2009-10-21 2014-08-27 Allergan, Inc. Alpha adrenergic receptor modulators

Also Published As

Publication number Publication date
ES2588059T3 (es) 2016-10-28
CA2833339C (fr) 2020-09-15
HRP20161024T1 (hr) 2016-11-04
EP2699545B1 (fr) 2016-05-25
JP5986625B2 (ja) 2016-09-06
JP2014514316A (ja) 2014-06-19
LT2699545T (lt) 2016-09-26
SMT201600284B (it) 2016-11-10
CN103619814B (zh) 2016-01-20
PL2699545T3 (pl) 2017-01-31
CA2833339A1 (fr) 2012-10-26
US9303019B2 (en) 2016-04-05
EP2699545A1 (fr) 2014-02-26
SI2699545T1 (sl) 2016-12-30
DK2699545T3 (en) 2016-08-29
US20140045910A1 (en) 2014-02-13
WO2012143660A1 (fr) 2012-10-26
RS55061B1 (sr) 2016-12-30
HUE030432T2 (en) 2017-05-29
CN103619814A (zh) 2014-03-05
PT2699545T (pt) 2016-08-30

Similar Documents

Publication Publication Date Title
CY1123476T1 (el) Τροποποιητες πυρηνικης μεταφορας και χρησεις αυτων
CY1122730T1 (el) 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων
CY1124729T1 (el) Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου
CY1124436T1 (el) Δικυκλικες ετεροκυκλικες ενωσεις και χρησεις αυτων στη θεραπεια
CY1121882T1 (el) Αναστολεις πυραζολυλο κινοξαλινο κινασης
CY1122292T1 (el) Ενωσεις και μεθοδοι για αντιϊικη αγωγη
CY1124298T1 (el) Φενφλουραμινη για χρηση στην θεραπευτικη αντιμετωπιση του συνδρομου dravet
CY1120318T1 (el) Υποκατεστημενες βενζυλινδαζολες για χρηση ως αναστολεις κινασης bub1 στη θεραπευτικη αντιμετωπιση υπερπολλαπλασιαστικων ασθενειων
CY1121849T1 (el) Μεθοδοι και συνθεσεις για τη θεραπεια του καρκινου
CY1119798T1 (el) Μορφη iv υδροχλωρικης ιβαμπραδινης
CY1122483T1 (el) Λυοφιλοποιημενες παρασκευες μελφαλανης φλουφεναμιδης
CL2013003313A1 (es) Compuestos derivados de 2,4-diaminoquinazolinas, sales o solvatos farmacéuticamente aceptables; composición farmacéutica que los comprende; y uso en el tratamiento de un trastorno en el que interviene la modulación de tlr7 y/o tlr8.
EA201591363A1 (ru) Аналоги тиадиазола и способы лечения состояний, связанных с дефицитом smn
CY1112813T1 (el) 4-(4-κυανο-2-θειοαρυλ)διϋδροπυριμιδινονες και η χρηση αυτων
TR201908596T4 (tr) Spiro-laktam NMDA reseptörü modülatörleri ve bunların kullanımları.
CY1124331T1 (el) Αυξημενη βιοδιαθεσιμοτητα δραστικης ουσιας σε θεραπεια ναλτρεξονης
CY1121628T1 (el) 7-βενζυλ-4-(2-μεθυλοβενζυλ)-2,4,6,7,8,9-εξαϋδροϊμιδαζο[1,2-α]πυριδο[3,4-ε]πυριμιδιν-5(1η)-ονη, αλατα αυτης και μεθοδοι χρησης
UY34775A (es) Uso de laquinimod en alta dosis para el tratamiento de la esclerosis múltiple
CY1121554T1 (el) Παραγωγο πυρανοχρωμενυλ-φαινολης, και φαρμακευτικη συνθεση για αγωγη μεταβολικου συνδρομου ή φλεγμονωδους παθησης
TR201909447T4 (tr) Aramkol tuzları.
CR20150211A (es) Compuestos diméricos
EA201691566A1 (ru) Применение производных пиридазина для предупреждения или лечения атаксического синдрома
CY1118585T1 (el) Ενωση βενζοθειαζολονης
CY1119522T1 (el) (r)- πιρλινδολη και τα φαρμακευτικως αποδεκτα αλατα αυτης για χρηση στην ιατρικη
PH12015500185B1 (en) Azaheterocycles as bir2 and/or bir3 inhibitors